{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.0/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Verapamil",
            "Path": "../../Verapamil-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 10 mg (bol), Smith 1984, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD, Mooy 1985, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD, Mooy 1985, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD, Johnston 1981, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD, Johnston 1981, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 10mg SD (10min), Abernethy 1985, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120mg SD, Abernethy 1985, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 10mg SD (10min), Barbarash 1988, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD, Barbarash 1988, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 10mg SD (10min), Wing 1985, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80mg SD, Wing 1985, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD, Smith 1984, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 40 mg SD, John 1992, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 60 mg SD, Choi 2008, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 60 mg SD, Choi 2008, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD, Hla 1987, n=10",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg MD, Hla 1987, n=10",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 160 mg SD, Mikus 1990, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 160 mg SD, Mikus 1990, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "iv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 240 mg SD, Karim 1995, n=12",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6",
                  "SectionReference": "ct-profiles"
                },
                {
                  "Project": "Verapamil",
                  "Simulation": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6",
                  "SectionReference": "ct-profiles"
                }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plot for concentration in plasma",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                    "Groups": [
    {
      "Caption": "Intravenous administration",
      "Symbol": "Circle",
      "OutputMappings": [
        {
          "Project": "Verapamil",
          "Simulation": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 10 mg (bol), Smith 1984, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 10mg SD (10min), Abernethy 1985, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 10mg SD (10min), Barbarash 1988, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 10mg SD (10min), Wing 1985, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "iv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.",
          "Color": "#FF0000"
        }
      ]
    },
    {
      "Caption": "Oral administration",
      "Symbol": "Square",
      "OutputMappings": [
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
          "Output": "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD, Mooy 1985, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD, Mooy 1985, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD, Johnston 1981, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD, Johnston 1981, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120mg SD, Abernethy 1985, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD, Barbarash 1988, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80mg SD, Wing 1985, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD, Smith 1984, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 40 mg SD, John 1992, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 60 mg SD, Choi 2008, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 60 mg SD, Choi 2008, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
          "Output": "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
          "Output": "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD, Hla 1987, n=10",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg MD, Hla 1987, n=10",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 160 mg SD, Mikus 1990, n=1",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 160 mg SD, Mikus 1990, n=1",
          "Output": "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10",
          "Output": "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 240 mg SD, Karim 1995, n=12",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        },
        {
          "Project": "Verapamil",
          "Simulation": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6",
          "Output": "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)",
          "ObservedData": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)",
          "Color": "#FF0000"
        }
      ]
    }
  ]
                  
                  
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Verapamil",
            "Name": "R-Verapamil",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Verapamil",
            "Name": "S-Verapamil",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Verapamil",
            "Name": "R-Norverapamil",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Verapamil",
            "Name": "S-Norverapamil",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Verapamil",
            "Name": "Solution",
            "Type": "Formulation",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Verapamil",
            "Name": "Retard Tablet Verapamil (Knoll)",
            "Type": "Formulation",
            "SectionReference": "final-input-parameters"
        }
    ],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Reference": "methods",
            "Title": "Methods",
"Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Reference": "modeling-strategy",
                    "Title": "Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Reference": "methods-data",
                    "Title": "Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Reference": "model-parameters-and-assumptions",
                    "Title": "Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Reference": "results-and-discussion",
            "Title": "Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Reference": "final-input-parameters",
                    "Title": "Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Reference": "diagnostics-plots",
                    "Title": "Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Reference": "ct-profiles",
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md"
                }
            ]
        },
        {
            "Reference": "conclusion",
            "Title": "Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Reference": "main-references",
            "Title": "References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}